Kim Robert Young bought FDMT
February 5, 2024 · Form 4 insider transaction
Kim Robert Young bought 12,000 shares of 4D Molecular Therapeutics, Inc. at $18.66 per share, a transaction worth $223.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,000
Price
$18.66
Total value
$223.9K
InsiderKim Robert Young
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 5, 2024
Filing dateFebruary 7, 2024
Shares owned after13,595
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on April 11, 2023.